Intco Medical Technology Co., Ltd. (SHE:300677)
China flag China · Delayed Price · Currency is CNY
49.42
+2.47 (5.26%)
Nov 17, 2026, 3:04 PM CST

Intco Medical Technology Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
13,1209,9269,5236,9196,61416,240
Revenue Growth
33.20%4.23%37.65%4.61%-59.27%17.37%
Gross Profit
4,2982,3742,176942.35837.659,973
Operating Income
2,531909901.75-162.49-70.288,583
Net Income
298.441,0111,465383629.077,430
Earnings Per Share
0.461.572.260.580.9511.00
EPS Growth
-82.80%-30.53%289.65%-38.95%-91.36%-2.73%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Personal Protection
8,8358,6006,1806,00515,807
Rehabilitation Nursing Category
447.87457.67395.79377.81254.73
Other
642.77465.51343.1230.95177.91
Total
9,9269,5236,9196,61416,240

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
8,05013,19118,75113,1818,2708,277
Total Debt
17,76017,50113,2697,1661,580292.05
Net Cash (Debt)
-9,710-4,3105,4826,0156,6897,985
Net Cash Growth
---8.86%-10.08%-16.23%30.68%
Net Cash Per Share
-14.99-6.698.459.1110.1011.82

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
3,3001,8851,079502.411,0658,680
Capital Expenditures
-1,512-2,575-1,789-1,439-1,715-5,444
Free Cash Flow
1,788-689.72-710.37-936.28-649.763,236
Free Cash Flow Growth
------43.12%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
32.76%23.91%22.85%13.62%12.67%61.41%
Operating Margin
19.29%9.16%9.47%-2.35%-1.06%52.85%
Pretax Margin
5.26%12.39%16.89%6.40%10.65%53.26%
Profit Margin
2.27%10.18%15.39%5.54%9.51%45.75%
FCF Margin
13.63%-6.95%-7.46%-13.53%-9.82%19.93%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1500.1500.1500.0800.0990.625
Dividend Per Share Growth
33.33%0%87.50%-19.00%-84.20%-66.25%
Dividend Yield
0.30%0.38%0.59%0.34%0.47%1.30%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
107.2724.9511.0740.0122.054.28
Forward PE
16.8915.8311.931.461.465.01
P/FCF Ratio
17.90----9.83
PS Ratio
2.442.541.702.222.101.96